Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for breast cancer prevention in postmenopausal women with BRCA1/2 mutation
2007-000687-24Phase 3Active
- Sponsor
- Unicancer
- Start
- Feb 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of letrozole in breast adenocarcinoma, sponsored by Unicancer. Primary endpoint: Incidence reduction of invasive breast cancer. Started Feb 2007; status: active.
02
Drugs
letrozole
03
Conditions
breast adenocarcinoma
Beyond the preview
Go deeper on 2007-000687-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000687-24.